Mirae Asset Global Etfs Holdings Ltd. Standard Biotools Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.9 Billion
- Q4 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Standard Biotools Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 168,777 shares of LAB stock, worth $204,220. This represents 0.0% of its overall portfolio holdings.
Number of Shares
168,777
Previous 161,473
4.52%
Holding current value
$204,220
Previous $311,000
5.14%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding LAB
# of Institutions
143Shares Held
274MCall Options Held
6.7KPut Options Held
48.7K-
Casdin Capital, LLC New York, NY71.3MShares$86.2 Million10.73% of portfolio
-
Viking Global Investors LP58.7MShares$71 Million0.35% of portfolio
-
Black Rock Inc. New York, NY21.8MShares$26.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.2MShares$20.8 Million0.0% of portfolio
-
Morgan Stanley New York, NY16.9MShares$20.4 Million0.0% of portfolio
About STANDARD BIOTOOLS INC.
- Ticker LAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 78,654,800
- Market Cap $95.2M
- Description
- Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...